Dividend Investing Ideas Center
Critical Facts You Need to Know About Preferred Stocks
Have you ever wished for the safety of bonds, but the return potential...
You take care of your investments. We like that.
Upgrade to Premium to access your Watchlist and more.
Direxion Daily Healthcare Bull 3X Shares
ETF
CURE
Payout Change
Pending
Price as of:
$106.52
+0.14
+0.13%
primary theme
Leveraged Equity
CURE (ETF)
Direxion Daily Healthcare Bull 3X Shares
Payout Change
Pending
Price as of:
$106.52
+0.14
+0.13%
primary theme
Leveraged Equity
CURE (ETF)
Direxion Daily Healthcare Bull 3X Shares
Payout Change
Pending
Price as of:
$106.52
+0.14
+0.13%
primary theme
Leveraged Equity
Name
As of 11/22/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
5.5%
1 yr return
20.3%
3 Yr Avg Return
-2.8%
5 Yr Avg Return
11.4%
Net Assets
$214 M
Holdings in Top 10
70.5%
52 WEEK LOW AND HIGH
$106.4
$87.99
$142.11
Expenses
OPERATING FEES
Expense Ratio 0.96%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Name
As of 11/22/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
CURE - Profile
Distributions
- YTD Total Return 5.5%
- 3 Yr Annualized Total Return -2.8%
- 5 Yr Annualized Total Return 11.4%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.05%
- Dividend Yield 1.3%
- Dividend Distribution Frequency Quarterly
Fund Details
-
Legal NameDirexion Daily Healthcare Bull 3X Shares
-
Fund Family NameDirexion Shares ETF Trust
-
Inception DateJun 15, 2011
-
Shares Outstanding1900008
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerPaul Brigandi
Fund Description
The Index is provided by S&P Dow Jones Indices (the “Index Provider”) and includes domestic companies from the healthcare sector, which includes the following industries: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology. The Index is one of eleven Select Sector Indexes developed and maintained in accordance with the following criteria: (1) each of the component securities in the Index is a constituent company of the S&P 500® Index; (2) each stock in the S&P 500® Index is allocated to one of the Select Sector Indexes; and (3) the Index is calculated by the Index Provider using a modified “market capitalization” methodology, which is a hybrid between equal weighting and conventional capitalization weighting with the weighting capped for the largest stocks included in the Index. This design ensures that each of the component stocks within a Select Sector Index is represented proportionate to the total market capitalization of such Select Sector Index.As of December 29, 2023, the Index had 64 constituents, which had a median total market capitalization of $40.2 billion, total market capitalizations ranging from $7.5 billion to $553.4 billion and were concentrated in the healthcare sector. The Index is rebalanced quarterly.The components of the Index and the percentages represented by various sectors in the Index may change over time. The Fund will concentrate its investment in a particular industry or group of industries (i.e., hold 25% or more of its total assets in the stocks of a particular industry or group of industries) to approximately the same extent as the Index is so concentrated.The Fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments, such as swap agreements, securities of the Index, and exchange-traded funds ("ETFs") that track the Index, that, in combination, provide 3X daily leveraged exposure to the Index, consistent with the Fund's investment objective. The financial instruments in which the Fund most commonly invests are swap agreements and futures agreements which are intended to produce economically leveraged investment results.The Fund may invest in the securities of the Index, a representative sample of the securities in the Index that has aggregate characteristics similar to those of the Index, an ETF that tracks the Index or a substantially similar index, and may utilize derivatives, such as swaps or futures on the Index or on an ETF that tracks the same Index or a substantially similar index, that provide leveraged exposure to the above.The Fund seeks to remain fully invested at all times, consistent with its stated investment objective, but may not always have investment exposure to all of the securities in the Index, or its weighting of investment exposure to securities or industries may be different from that of the Index. In addition, the Fund may invest directly or indirectly in securities not included in the Index. In all cases, the investments would be designed to help the Fund track the Index.The Fund will attempt to achieve its investment objective without regard to overall market movement or the increase or decrease of the value of the securities in the Index. At the close of the markets each trading day, Rafferty rebalances the Fund’s portfolio so that its exposure to the Index is consistent with the Fund’s investment objective. The impact of the Index’s movements during the day will affect whether the Fund’s portfolio needs to be re-positioned. For example, if the Index has risen on a given day, net assets of the Fund should rise, meaning that the Fund’s exposure will need to be increased. Conversely, if the Index has fallen on a given day, net assets of the Fund should fall, meaning the Fund’s exposure will need to be reduced. This re-positioning strategy typically results in high portfolio turnover. On a day-to-day basis, the Fund is expected to hold ETFs and money market funds, deposit accounts with institutions with high quality credit ratings (i.e. investment grade or higher), and/or short-term debt instruments that have terms-to-maturity of less than 397 days and exhibit high quality credit profiles, including U.S. government securities and repurchase agreements. The Fund may lend securities representing up to one-third of the value of the Fund’s total assets (excluding the value of the collateral received).The terms “daily,” “day,” and “trading day,” refer to the period from the close of the markets on one trading day to the close of the markets on the next trading day. The Fund is “non-diversified,” meaning that a relatively high percentage of its assets may be invested in a limited number of issuers of securities. Additionally, the Fund’s investment objective is not a fundamental policy and may be changed by the Fund’s Board of Trustees without shareholder approval.Because of daily rebalancing and the compounding of each day’s return over time, the return of the Fund for periods longer than a single day will be the result of each day’s returns compounded over the period, which will very likely differ from 300% of the return of the Index over the same period. The Fund will lose money if the Index performance is flat over time, and as a result of daily rebalancing, the Index’s volatility and the effects of compounding, it is even possible that the Fund will lose money over time while the Index’s performance increases over a period longer than a single day.
Read More
CURE - Performance
Return Ranking - Trailing
| Period | CURE Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 5.5% | -69.2% | 140.0% | 82.91% |
| 1 Yr | 20.3% | -59.2% | 185.5% | 81.01% |
| 3 Yr | -2.8%* | -50.2% | 35.6% | 62.66% |
| 5 Yr | 11.4%* | -40.0% | 58.2% | 44.94% |
| 10 Yr | 13.7%* | -37.5% | 43.2% | 31.16% |
* Annualized
Return Ranking - Calendar
| Period | CURE Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | -11.3% | -56.9% | 257.9% | 89.24% |
| 2022 | -20.8% | -91.0% | 124.5% | 20.25% |
| 2021 | 88.2% | -79.4% | 168.2% | 10.13% |
| 2020 | 4.5% | -97.4% | 132.6% | 59.49% |
| 2019 | 54.8% | -53.1% | 229.8% | 35.26% |
Total Return Ranking - Trailing
| Period | CURE Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 5.5% | -69.2% | 140.0% | 82.91% |
| 1 Yr | 20.3% | -59.2% | 185.5% | 81.01% |
| 3 Yr | -2.8%* | -50.2% | 35.6% | 62.66% |
| 5 Yr | 11.4%* | -40.0% | 58.2% | 44.94% |
| 10 Yr | 13.7%* | -37.5% | 43.2% | 31.16% |
* Annualized
Total Return Ranking - Calendar
| Period | CURE Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | -9.4% | -55.8% | 259.6% | 89.24% |
| 2022 | -20.5% | -91.0% | 130.7% | 21.52% |
| 2021 | 88.3% | -79.4% | 168.2% | 10.13% |
| 2020 | 4.9% | -97.4% | 132.6% | 62.03% |
| 2019 | 55.7% | -52.7% | 231.9% | 35.90% |
CURE - Holdings
Concentration Analysis
| CURE | Category Low | Category High | CURE % Rank | |
|---|---|---|---|---|
| Net Assets | 214 M | 1.5 M | 22.2 B | 25.75% |
| Number of Holdings | 70 | 5 | 2009 | 42.59% |
| Net Assets in Top 10 | 140 M | 1.08 M | 9.23 B | 24.69% |
| Weighting of Top 10 | 70.46% | 13.9% | 185.3% | 30.25% |
Top 10 Holdings
- GOLDMAN FINL SQ TRSRY INST 506 14.64%
- HEALTH CARE SELECT SECTOR INDEX SWAP 10.08%
- Eli Lilly Co. COM NPV 9.18%
- UnitedHealth Group Inc. COM USD0.01 7.58%
- DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) 7.32%
- Johnson Johnson COM USD1.00 5.43%
- AbbVie Inc. COM USD0.01 4.68%
- HEALTH CARE SELECT SECTOR INDEX SWAP 4.12%
- Merck Co., Inc COM USD0.50 4.10%
- Thermo Fisher Scientific Inc COM USD1 3.35%
Asset Allocation
| Weighting | Return Low | Return High | CURE % Rank | |
|---|---|---|---|---|
| Stocks | 78.70% | 0.00% | 375.12% | 33.33% |
| Cash | 21.96% | 0.00% | 104.72% | 26.54% |
| Other | 16.48% | -7.39% | 99.69% | 58.02% |
| Preferred Stocks | 0.00% | 0.00% | 1.99% | 94.44% |
| Convertible Bonds | 0.00% | 0.00% | 0.32% | 94.44% |
| Bonds | 0.00% | 0.00% | 37.59% | 94.44% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | CURE % Rank | |
|---|---|---|---|---|
| Healthcare | 100.00% | 0.00% | 100.00% | 4.00% |
| Utilities | 0.00% | 0.00% | 100.00% | 94.40% |
| Technology | 0.00% | 0.00% | 100.00% | 96.00% |
| Real Estate | 0.00% | 0.00% | 100.00% | 94.40% |
| Industrials | 0.00% | 0.00% | 100.00% | 96.00% |
| Financial Services | 0.00% | 0.00% | 100.00% | 96.00% |
| Energy | 0.00% | 0.00% | 100.00% | 95.20% |
| Communication Services | 0.00% | 0.00% | 100.00% | 96.00% |
| Consumer Defense | 0.00% | 0.00% | 52.46% | 96.00% |
| Consumer Cyclical | 0.00% | 0.00% | 94.15% | 96.00% |
| Basic Materials | 0.00% | 0.00% | 100.00% | 96.80% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | CURE % Rank | |
|---|---|---|---|---|
| US | 78.70% | 0.00% | 375.12% | 33.33% |
| Non US | 0.00% | 0.00% | 20.00% | 94.44% |
CURE - Expenses
Operational Fees
| CURE Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.96% | 0.68% | 5.63% | 91.77% |
| Management Fee | 0.75% | 0.00% | 0.95% | 74.85% |
| 12b-1 Fee | 0.00% | 0.00% | 1.00% | 45.67% |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| CURE Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 4.75% | 4.75% | N/A |
| Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
| CURE Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | N/A | N/A | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| CURE Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | N/A | 0.00% | 266.00% | 20.75% |
CURE - Distributions
Dividend Yield Analysis
| CURE | Category Low | Category High | CURE % Rank | |
|---|---|---|---|---|
| Dividend Yield | 1.25% | 0.00% | 18.26% | 23.95% |
Dividend Distribution Analysis
| CURE | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Quarterly | Annually | Monthly | Quarterly |
Net Income Ratio Analysis
| CURE | Category Low | Category High | CURE % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.05% | -2.77% | 2.92% | 23.42% |
Capital Gain Distribution Analysis
| CURE | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Sep 24, 2024 | $0.333 | OrdinaryDividend |
| Jun 25, 2024 | $0.273 | OrdinaryDividend |
| Mar 19, 2024 | $0.355 | OrdinaryDividend |
| Dec 21, 2023 | $0.573 | OrdinaryDividend |
| Sep 19, 2023 | $0.454 | OrdinaryDividend |
| Jun 21, 2023 | $0.537 | OrdinaryDividend |
| Mar 21, 2023 | $0.487 | OrdinaryDividend |
| Dec 20, 2022 | $0.144 | OrdinaryDividend |
| Sep 20, 2022 | $0.184 | OrdinaryDividend |
| Jun 22, 2022 | $0.077 | OrdinaryDividend |
| Mar 22, 2022 | $0.035 | OrdinaryDividend |
| Dec 21, 2021 | $0.033 | OrdinaryDividend |
| Dec 22, 2020 | $0.006 | OrdinaryDividend |
| Sep 22, 2020 | $0.010 | OrdinaryDividend |
| Jun 23, 2020 | $0.016 | OrdinaryDividend |
| Mar 24, 2020 | $0.100 | OrdinaryDividend |
| Dec 23, 2019 | $0.000 | OrdinaryDividend |
| Sep 24, 2019 | $0.203 | OrdinaryDividend |
| Mar 19, 2019 | $0.088 | OrdinaryDividend |
| Dec 27, 2018 | $0.137 | OrdinaryDividend |
| Sep 25, 2018 | $0.086 | OrdinaryDividend |
| Jun 19, 2018 | $0.112 | OrdinaryDividend |
| Dec 19, 2017 | $0.070 | OrdinaryDividend |
| Dec 13, 2017 | $0.016 | CapitalGainShortTerm |
| Dec 12, 2013 | $0.214 | CapitalGainShortTerm |
| Mar 21, 2012 | $0.002 | OrdinaryDividend |
| Dec 13, 2011 | $0.092 | CapitalGainShortTerm |
CURE - Fund Manager Analysis
Managers
Paul Brigandi
Start Date
Tenure
Tenure Rank
Jun 15, 2011
10.97
11.0%
Paul Brigandi, the Fund’s Portfolio Manager, is primarily responsible for the day-to-day management of the Fund. An investment trading team of Rafferty employees assists Mr. Brigandi in the day-to-day management of the Fund subject to his primary responsibility and oversight. The Portfolio Manager works with the investment trading team to decide the target allocation of the Fund’s investments and on a day-to-day basis, an individual portfolio trader executes transactions for the Fund consistent with its target allocation. The members of the investment trading team rotate among the various series of the Trust, including the Fund periodically so that no single individual is assigned to a specific Fund for extended periods of time. Mr. Brigandi has been a Portfolio Manager at Rafferty since June 2004. Mr. Brigandi was previously involved in the equity trading training program for Fleet Boston Financial Corporation from August 2002 to April 2004. Mr. Brigandi is a 2002 graduate of Fordham University.
Tony Ng
Start Date
Tenure
Tenure Rank
Sep 30, 2015
6.67
6.7%
Tony Ng is a Portfolio Manager and joined Rafferty Asset Management in April 2006. He was previously a Team Leader in the Trading Assistant Group with Goldman Sachs from 2004 to 2006. Hg was employed with Deutsche Asset Management from 1998 to 2004. Mr. Ng graduated from State University at Buffalo in 1998.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 1.79 | 28.9 | 9.84 | 8.67 |
